Guggenheim initiated coverage of Metsera (MTSR) with a Buy rating and $56 price target The firm sees a “highly promising multi-billion ...

Goldman Sachs analyst Chris Shibutani initiated coverage of Metsera (MTSR) as an Early-Stage Biotech. Metsera is clinical-stage ...

New research finds older women achieve the best results with weight loss injections – thanks to consistent tracking and ...

While the outcomes can be positive, Consumer Reports warns there are important considerations, especially for older adults, ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5 to 7 percent of their weight had a 58% lower risk of ...

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) ("Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone ...

Are you on a weight loss journey but struggling to shed those extra kilos? You're not alone. Many people often feel lost about what to eat and do to reach their fitness goals, sometimes blindly ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company ...

To the editor: All Republicans on the Senate Committee on Health, Education, Labor and Pensions — including members who are physicians — voted to confirm Robert F. Kennedy Jr. to regulate ...